However, another study in mice with the c9orf72 mutation indicated the type II diabetes medication metformin might have therapeutic potential for ALS (Zu et al., 2020), indicating ALS risk may be moderated differentially across classes of diabetes medication. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.